We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » MedPAC Supports Lowering Generic Copay Under Part D to Spur Use
MedPAC Supports Lowering Generic Copay Under Part D to Spur Use
January 4, 2012
A proposed Medicare Payment Advisory Commission (MedPAC) recommendation for wider copays between brand and generic drugs may lead to greater use of the cheaper medicines under Medicare Part D.